These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3550071)
21. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial. Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681 [TBL] [Abstract][Full Text] [Related]
22. Maintenance therapy of rheumatoid arthritis and of osteoarthrosis with proglumetacin. Bozsóky S; Zahumenszky Z Pharmatherapeutica; 1983; 3(5):305-13. PubMed ID: 6844368 [TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial to evaluate the efficacy of community based physical therapy in the treatment of people with rheumatoid arthritis. Bell MJ; Lineker SC; Wilkins AL; Goldsmith CH; Badley EM J Rheumatol; 1998 Feb; 25(2):231-7. PubMed ID: 9489812 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study. Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722 [TBL] [Abstract][Full Text] [Related]
26. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone. Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639 [TBL] [Abstract][Full Text] [Related]
27. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Nuki G; Bresnihan B; Bear MB; McCabe D; Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223 [TBL] [Abstract][Full Text] [Related]
28. A single-blind crossover trial of the anti-inflammatory drug sodium meclofenamate and placebo, including an evaluation of hand grip and of lymphocyte responsiveness. Palmer DG; Barbezat GO; Gibbins BL; Grennan DM; Lum J; Myers DB; Wilson K Curr Med Res Opin; 1981; 7(6):359-69. PubMed ID: 7016448 [TBL] [Abstract][Full Text] [Related]
29. Regional intravascular sympathetic (RIS) block with guanethidine (Ismelin). Aarts HF; Zeegers A; van der Meer C Neth J Surg; 1980; 32(4):135-41. PubMed ID: 7465089 [TBL] [Abstract][Full Text] [Related]
30. Changes in human forearm blood flow after intravenous regional sympathetic blockade with guanethidine. Thomsen MB; Bengtsson M; Lassvik C; Lewis DH; Elfström J Acta Chir Scand; 1982; 148(8):657-61. PubMed ID: 7170901 [TBL] [Abstract][Full Text] [Related]
31. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis. Katona G; Vargas RB Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928 [TBL] [Abstract][Full Text] [Related]
32. A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis. Kadir N; Grayson MF; Campbell ED Ann Clin Res; 1983; 15(1):4-9. PubMed ID: 6134490 [TBL] [Abstract][Full Text] [Related]
33. Sympathetic nerve blocks in refractory sympathetic dystrophy syndrome. Hennart D; Leon M; Sylin P; Appelboom T Acta Orthop Belg; 1999 Mar; 65(1):83-5. PubMed ID: 10217006 [TBL] [Abstract][Full Text] [Related]
34. Transcutaneous electrical nerve stimulation in rheumatoid arthritis. Abelson K; Langley GB; Sheppeard H; Vlieg M; Wigley RD N Z Med J; 1983 Mar; 96(727):156-8. PubMed ID: 6600826 [TBL] [Abstract][Full Text] [Related]
35. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients. Flint-Wagner HG; Lisse J; Lohman TG; Going SB; Guido T; Cussler E; Gates D; Yocum DE J Clin Rheumatol; 2009 Jun; 15(4):165-71. PubMed ID: 19279507 [TBL] [Abstract][Full Text] [Related]
36. Physical and exercise therapy for treatment of the rheumatoid hand. Buljina AI; Taljanovic MS; Avdic DM; Hunter TB Arthritis Rheum; 2001 Aug; 45(4):392-7. PubMed ID: 11501728 [TBL] [Abstract][Full Text] [Related]
37. The effects of intravenous regional guanethidine and reserpine. A controlled study. McKain CW; Urban BJ; Goldner JL J Bone Joint Surg Am; 1983 Jul; 65(6):808-11. PubMed ID: 6863363 [TBL] [Abstract][Full Text] [Related]
38. Effect of guanethidine on the natural history of post-traumatic algodystrophy. Field J; Atkins RM Ann Rheum Dis; 1993 Jun; 52(6):467-9. PubMed ID: 7686739 [TBL] [Abstract][Full Text] [Related]
39. Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study. Jadad AR; Carroll D; Glynn CJ; McQuay HJ J Pain Symptom Manage; 1995 Jan; 10(1):13-20. PubMed ID: 7536227 [TBL] [Abstract][Full Text] [Related]
40. A comparison of regional intravenous guanethidine and reserpine in reflex sympathetic dystrophy. A controlled, randomized, double-blind crossover study. Rocco AG; Kaul AF; Reisman RM; Gallo JP; Lief PA Clin J Pain; 1989 Sep; 5(3):205-9. PubMed ID: 2520406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]